Filing Details

Accession Number:
0001104659-23-028479
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-03 16:47:47
Reporting Period:
2023-03-01
Accepted Time:
2023-03-03 16:47:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Cfo, Evp & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-01 10,974 $11.33 111,588 No 4 M Direct
Common Stock Disposition 2023-03-01 10,974 $36.33 100,614 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2023-03-01 10,974 $0.00 10,974 $11.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,826 2026-03-17 No 4 M Direct
Footnotes
  1. Includes 134 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2022.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022.
  3. Shares subject to the option are fully vested and immediately exercisable.